1. Ford, E. S., Schulze, M. B., Bergmann, M. M., Thamer, C., Joost, H. G., & Boeing, H. (2008). Liver enzymes and incident diabetes: Findings from the European Prospective Investigation Into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care, 31, 1138–1143.
2. Cho, N. H., Jang, H. C., Choi, S. H., Kim, H. R., Lee, H. K., Chan, J. C., et al. (2007). Abnormal liver function test predicts type 2 diabetes: A community-based prospective study. Diabetes Care, 30(10), 2566–2568.
3. Sato, K. K., Hayashi, T., Nakamura, Y., Harita, N., Yoneda, T., Endo, G., et al. (2008). Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care, 31, 1230–1236.
4. Iqbal, A., Iftikhar, U., Ali, F. A., Memon, S., & Zuberi, N. (2010). Comparison of gamma glutamyltransferase in normal and in type 2 diabetics. Journal of Pakistan Medical Association, 60(11), 945–948.
5. Takahashi, K., Uchiyama, H., Yanagisawa, S., & Kamae, I. (2006). Logistic regression and ROC analysis of group-based screening for predicting incidence in 4 yrs. Kobe Journal of Medical Sciences, 52, 171–180.